Reddit Posts
21 MAY 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY
π $GOSS (Gossamer Bio) DD β High Risk Biotech with 5xβ20x Potential?
10 APRIL 2026 , WHAT ARE THE BIGGEST WINNERS PRE-MARKET ?
26 MARCH 2026 , WHAT ARE THE BIGGEST WINNERS IN STOCK MARKET RACE TODAY ?
Binary Event: Phase III Data Release -XENE - Xenon Pharma
05 MARCH 2025 WHAT IS MOVING THE STOCKS TODAY
WHICH COMPANIES ARE MAKING MONEY FROM WARS? , WHILE OTHER ARE WORRIED ABOUT, WHERE THE BOMBS ARE GOING NEXT ?
GOSS Stock Update 3: The 85% Collapse, the $9 Target, and the FRI Data That Could Flip the Entire Narrative
GOSS STOCK UPTADE Missed Phase 3 by a Hair, Dropped 85%β¦ But This Story Is NOT Over (June FDA Meeting Ahead)
GOSS STOCK : Itβs Chaotic. Lawsuits Are Brewing. And Thatβs Exactly Why a Rally Is Possible.
Why Iβm Bullish on $GOSS
GOSS - Gossamer Bio - Phase III: Binary Event
GOSS Phase III data soon β am I missing something or is this setup weird?
Gossamer Bio - Opportunity within the next 3 weeks - I like the stock
Gossamer Bio (GOSS) - Quick Follow-Up on My Post 9 Months Ago
Why is no one talking about $GOSS?
Gossamer Bio (GOSS)
Not even sure what $GOSS does but I yolo'd in and it started to rip
[DD] GOSS Pushed through Resistance today with a tightly held float and unusual Pressure building, and Days to Cover is Kind of Insane
Special Situation $GOSS w/over 23 million shares short
Special Situation $GOSS w/over 23 million shares short
Special Situations: $DSS, $GOSS, $MIGI, $PRPH
The Biotech Train is leaving the Station. All Aboard!: $LUMO, $BIVI, $GOSS
Top penny stocks to keep an eye on for less than $1
Gossamer Bio Inc. (GOSS) Has Recovered 24.79% From Its Low
GOSS - Several indicators this should pop tomorrow.
Short Squeeze Pennies To Watch - $RAD $SANA $GOEV $GOSS
GOSS is the real deal and has been shorted to a bargain price
$GOSS Gossamer Bio Inc According to Yahoo Finance: 130.60% of Shares Held by Institutions
$GOSS ramping up. 7% today, what tomorrow?
GOSS fell from $9 to 1.59 today, anyone with more info about?
$GOSS is a new shortsqueeze opportunity?
$GOSS is a new shortsqueeze opportunity?
Mentions
$GOSS already up 10%, was just talking about it yesterday. They'll have a mid june meeting with FDA and if it goes well, the stock could reach at least double its current value
I agree with you, been holding GOSS for 2 years now. They def have potential.
# $GOSS: maybe not dead yet For GOSS, the mid june meeting with FDA could be massively underestimated by the market. It is true that the study of PROSERA 3 has failed, but the study missed the statistical threshold by a very narrow margin (0,032 vs. 0,025), while still showing clinically meaningful improvement in PAH patients. This is why the upcoming FDA interaction matters a lot. The market thinks that $GOSS is already dead, but i believe that the FDA meeting could completely change the sentiment if the agency singnals openness to a filling path. GOSS will likely argue that, despite narrowly missing the statistical threshold in PROSERA, Seralutnib showed benefit and that the totality of evidence supports a viable NDA path, potentially with a narrower label or additional post-approval requirements. I'm taking the investment on $GOSS more like a bet, the stock is currently worth around $0.20 but could increase significantly if the mid-June FDA meeting ends positively. [](https://preview.redd.it/goss-maybe-not-dead-yet-v0-4xndwzbztc3h1.png?width=940&format=png&auto=webp&s=0b9e341deb9b7949543f936f4ce4fe643d0fd631)
If i'll start to think that they'll accept the offer, i might sell GOSS, accept the 2k loss and invest the remaining 3k on GDC or saving 2k and invest 1k.. i really don't know what to do
Now $GOSS is down at 0.20$, i really don't know if it will ever recover till the end of the year
GOSS was too far OTM for more puts so I scolded Grok for bad advise and he gave me these instead.
I think I'm taking some winnings soon and going on GOSS, IOBT or something of the sort. Even if it just sits for a while
Im in VSTD and GOSS
GOSS drama for the past couple weeks after a failed Phase 3, it has been making a nice recovery so far
Not too late to get on the GOSS train
That GOSS drop is just asking for that bounce. And its 100% gonna come
Wtf is up with GOSS? No rebound?
GOSS massively up expected. π π
Anyone here also hopefully GOSS goes back to 1?
Got into GOSS yesterday with that dip (probably wasnt even a dip and falls more), also in AGAE with the highest possible price it was couple days ago (trying to break even atleast) and also in LGBJ. Main investment is IBRX which averages around 6$.
Most biotech's drug trials fail in phase 3. Likely success is guess work. $GOSS has no future, likely to disappear soon like many other small biotech with approved products and no revenue to sustain continued operation.
I jumped onto GOSS dip. Can loose it all but also can run up little bit !
I fell asleep and woke up to an 82% on GOSS. Shouldβve put a stop loss on before I fell asleep
GOSS failure (but very close to stat sig) w/ inhaled same MoA is the perfect scenario for IKT
βInstitutional ownership is sitting at roughly 81%. Big players like Vanguard and State Street have been holding/increasing positions, signaling that the "pros" are betting on a clinical win.β Institutions, like Vanguard, offer ETFs that include GOSS. And because you dont know what part of their holdings is for ETFs and what part is for a single investment thesis on GOSS you cannot really make use of this number. It could be 100% single investment thesis or 0% and anything in between In general, alot of small cap pharma stocks have high institutional ownership, even tho 9/10 of these stocks go bust.
Check out $GOSS Might drop some really good news today
[Hereβs](https://open.substack.com/pub/biotechdistilled/p/gossamer-bio-goss-scientific-deep?r=4tawgv&utm_medium=ios) my dive into GOSS.
Hi Lobo, yes GOSS will certainly release results this coming Monday or Tuesday (2/23 or 2/24). Obviously this isnβt confirmed iβm speculating but based on patterns I came to this assumption. The company said sometime in February and typically Trial 3 results are released on Mondays or Tuesdays. Good luck soldier.
This is not financial advice, but you could buy 1 decent call option on GOSS because of that big thing they want to reveal next week perhaps. One of those costs less than $160 today.
You are using the wrong strategies for sure. Have you considered selling options instead, i.e. r/thetagang? Given that you don't have a job currently, getting income by selling cash-secured puts or covered calls could help you get through your unemployment stage until a job comes around. For example, amd this is a very high risk strategy by theta standards, you could sell CSPs on GOSS and get about 120-125 dollars for every 200 you put up as collateral. Baring a >50% drop in the stock, you profit. 80k would be 400 put contracts at $2, giving you about $48k in premium credit. If the stock stays above $0.80, you win, if it stays above $2 for the next month, you collect the entire profit. If it drops to $1.90 on Monday and you get assigned 40,000 share of a volatile biotech company, just sell 400 CCs for your cost basis strike. This is of course risky, but there are safer moves out there that let you use your capital to generate income without the high reward, low probability 0DTE trades.
GOSS Trial 3 Results released tomorrow.
Hoping GOSS has good news.
GOSS. Insiders purchased a total of 1.942M shares since Oct 2025. Never sold. Hedge fund manager Joseph Edelman 2.5B net worth purchased 3.8M shares in Q3 2025. On top of that GOSS has a merger agreement with Respira Therapeutics, they can pull the agreement anytime before December 2027. GOSS has the capacity to burn cash until 2027. Finally, GOSS has trial 3 top line results sometime in February. This binary play is a perfect setup and a no brainer. Invest while you can gentlemen.
Insiders massively purchased Goss on January 5th. Trial 3 results coming sometime this month. Purchase GOSS ASAP.
GOSS catalyst for February.
Very appreciated! Iβm hoping things go well for GOSS, only one Iβm currently in.
GOSS calls, iykyk
Sitting with 10k shares, Iβm all in with GOSS seems promising with the February catalyst.
Thank you for the insight. Snagged 130 shares. I typically buy shares in 1 biotech company a year. Last year GOSS was good to me. Letβs see what happens next!
GOSS about to have a new drug approved
spam posts every day abt a sh\*tty website, lol. There is no big flow in GOSS, I checked unusualwhales.
$GOSS $4 calls high OI 1/16/2026, biotech, has a huge gap fill to $8
I was in GOSS for a while, but at this price the risk feels asymmetric to the downside. The lack of obvious adverse events sounds encouraging, but it also raises the real possibility that efficacy is simply not strong enough to meet the primary endpoint. We have seen this recently with XOMAβs partner Rezolute missing in Phase 3, and XOMA is also tied to Gossamer. Late stage trials still fail at meaningful rates, and PAH in particular has noisy endpoints and significant patient heterogeneity. What worries me more is the setup from here. If the data are anything short of clearly positive, the stock likely reprices hard, and even decent but ambiguous results may not be enough to support the valuation. Burn continues, and it seems increasingly likely they need to raise more cash before or after data, which adds dilution risk at a time when sentiment would already be fragile. There will be winners and losers here, but today this looks more like a binary gamble than a mispriced opportunity. I would rather step aside than ride that coin flip, but I will be watching closely.
GOSS (Bio), SOUN (AI), TSLA (Tech/Auto), NVDA (AI), META, CRWV (AI). These are all priced at a discount right now. Not saying it won't go lower, but eventually these stocks are bound to shoot back up!
Anyone in long on GOSS? It's definitely not a momentum play, but analysts have its price target \~$8.50-$9 on average. It's currently at $2.38 with low volatility as of now. I'm thinking about opening a long position myself.
Β Agree. Iβm holding $GOSS rn, big news January - February.Β
I think GOSS is gonna pump tomorrow.
GOSS is dipping right now
GOSS is a little different from ATYR. ATYRβs big Phase 3 just missed its primary endpoint, while GOSS is still in the middle of its pivotal trial. PROSERA builds on the earlier TORREY Phase 2 β same drug, but much larger (390 vs 86 patients) and with a sicker cohort (74% FC III vs \~42% in TORREY, worse baseline walk distance and NT-proBNP). The design was refined to give a clearer read on efficacy, and topline results are expected Feb 2026.
Anyone know why GOSS is down?? analyst price is 8, strong buy, no update on phase 3 so far that i know of. No big news
So small caps pharma stocks are tricky, in that we dont know when the run up will start, could be before a decision, (Run up like GOSS 80c to 3.50), or it could be the PFUDFA date which is the 13Dec2025 and we see a 100% rise if there is not run up. Generally I try to buy before the run up so I do hold stocks a bit
Def looking at ACHV (PDUFA next year) SPRO (PDUFA next year with partner), GOSS (Data in Feb2026) and INO (Maybe approval mid 2026) along with QNCX (Data 1st Q 2026)
If anyoneβs interested in something not mentioned yet, $GOSS has been on my watchlist for a while and itβs been picking up momentum. Not in it yet, havenβt really done DD but Iβll come back with some in a bit
No catalyst today or near future (Phase 3 readout in Feb 2026), so I can't explain it - but GOSS continues to march up I've been slowly DCA'ing to my position, but feel like I've missed out trying to wait for a pullback. It's a 80% + institutional owned stock so I like the risk/reward profile
$GOSS is headed in the right direction. StockInvest.us projects a possible 100%+ gain over the next three months, with a 90% confidence range predicting the stock to land between $4.28 and $5.3. Itβs currently $2.51 btw
Much appreciated insight! All of my investments are in a Vanguard Roth IRA, so while Iβm making slight changes short term, most of my moves are geared toward the long run. Iβm 37. Iβm trying to stick with companies with large upside, while also being a little risky, hoping that βsmallβ investments payoff in the long run. Right now Iβm up 250% on OKLO and have positions in GOSS and APMX. Everything I have read and researched about RZLV is similar to OKLO in the sense that it has some very promising long-term potential. Iβm considering selling about 30 shares of OKLO that I bought at $20 to move into RZLV, but weβll see. I like that RZLV is being well received by many and I donβt think AI is going anywhere.
Throw GOSS in there. Itβs makin moves
I'll be watching GOSS next week for their commentary at investor conferences for any news on how their Phase 3 is going. Significant institutional ownership with a slow and steady price movement has caught my attention.
Anyone like the look of $GOSS
Anybody have any thoughts on GOSS?
Maybe you take you wanna take a look at GOSS?
Iβve been watching GOSS grow and grow for months. Itβs been pretty consistent
GOSS Technical analysis supports what the fundamentals are suggesting: Gossamer is gearing up for a parabolic move. The stock has begun forming a bullish pattern with increasing volume, indicating institutional accumulation. If the anticipated news delivers as expected, a move past $10 per share is not just possible, itβs probable. This is a stock thatβs been overlooked and underestimated. But that window is closing. The company is sending signals that something big is coming, and once the public announcement drops, the rush to get in could trigger a short squeeze and price surge rarely seen in this sector.
GOSS - Gossamer Bio at Sector Outperform With $11 Price Target. Price just over $2, take a look! Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Everyone should be looking at GOSS, almost doubling my money and going higher! $8 Price Target
OPTT and GOSS over the next week are worth keeping your eyes on
Anyone in GOSS? Been holding for a while and some nice movement today
$GOSS - currently $1.25, big institutional ownership, high call to put ratio, analyst forecasts average around $7 including Goldman Sachs
After doing my DD and consulting the shaman of the high plains. I have entered the realm of GOSS. Now for the magic 8-ball to guide me through this π€ͺ
GOSS is rising ranks pretty quick. Looks like ton of potential too!!
GOSS is rising ranks pretty quick. Looks like ton of potential too πΈ
I am long on $GOSS in both calls and stock, and seeing it creep up has me VERY happy.
What's the plan for GOSS? Any update? I went balls deep into this company. When GOSS should have update on this treatment? Is there any deadlines to meet?
$GOSS several folks were talking about this one last month, any other bagholders out there?
RONN is moving up AEMD dropped for a good buying opportunity GOSS is still affordable but rising KBLB will soon have a buyer and contracts and should soar ARRNF is mining Strategic Defense metals IMHO-NFA
GOSS does whatever it feels like, but it did see a 7% jump after earnings. I am bullish tomorrow and I do feel like we'll have a green day for once, but don't expect much from it.
Ronn, inc. LLAP, GOSS, AEMD, KULR
GOSS I keep telling yall https://www.insidermonkey.com/blog/why-is-gossamer-bio-inc-goss-the-best-one-dollar-stock-to-buy-now-1325917/
I can guarantee that seralutinib nebulizer by GOSS will be a huge success. Promising 2nd phase results. Promising positive interim results. Does not compete with MRKβs new drug. Route of administration is unique to pulomnary hypertension. Will gain huge market share. Probably can be extended to interstitial ling disease. Both multi billion markets. GOSS can probably go up to 25 a share
Saw this a week late lol. Came here to look at $GOSS stuff
No feelings but great call on GOSS